{"id":1007133,"date":"2026-09-30T09:29:52","date_gmt":"2026-09-30T13:29:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/"},"modified":"2026-09-30T09:29:52","modified_gmt":"2026-09-30T13:29:52","slug":"shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/","title":{"rendered":"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately"},"content":{"rendered":"<h2>\nLead Plaintiff Deadline November 2, 2026<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>NEW YORK, Sept.  30, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oQwpog0aZA1w0n25Lj1q45ZVrvl4TPsciCXktTSbG2bKGayEecCfyb_TNstHuTgVQxOI0VNc0HpOYRf-kGJzhzJRafIC0rtoPAwfLedHmS7A7D0XGLbrxYlVNeAqiuXPRUU78yw0uTlS-HLgdRtfFoTQvHlyY9L9oPih8g1nLC-7gyUJaY5zbnd8R2hu6k0FTWhUHd5jgstEs-or2KgXpA==\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP (\u201cWolf Haldenstein\u201d),<\/a> a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims &amp; Hers Health, Inc. (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims &amp; Hers securities between August 4, 2025,and July 29, 2026 (the &#8220;Class Period&#8221;).<\/p>\n<p>\n        <strong>Investors who purchased Hims &amp; Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026.<\/strong>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=awuz8cJK-EWhjhpGszUbbnLOsNr0Y-4O7F1S0Sml3KfEq-nekLckZexidlkbBTV9Ap8m6FsnxGQYf9ciq0SuuTwi0239qT6lnVHWuy89LUzpV1wwWhKeUbPBniBWonx0WEYFpWYFk5hdWxqWLrJ5s7fLETiscK4EkM_09m1V1Q2KkwAEgTGx8HugIjeLHR5J\" rel=\"nofollow\" target=\"_blank\">PLEASE CLICK HERE TO SUBMIT CONTACT AND TRADE INFORMATION<\/a>\n      <\/p>\n<p>\n        <strong>Allegations<\/strong>\n      <\/p>\n<p>The complaint alleges that, throughout the Class Period, Defendants issued materially false and\/or misleading statements and withheld material adverse facts from investors, including that:<\/p>\n<ul>\n<li>The Company shared consumers\u2019 health information with third-party advertising platforms;<\/li>\n<li>The Company charged consumers for prescriptions almost immediately after they submitted an intake form, despite representing that consumers would be able to consult with a medical provider to find a treatment that was \u201cright for them;\u201d<\/li>\n<li>The foregoing conduct exposed the Company to regulatory scrutiny;<\/li>\n<li>As a result, the Company faced the likelihood of incurring fees and penalties; and<\/li>\n<li>Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/li>\n<\/ul>\n<p>\n        <strong>The Disclosure<\/strong>\n      <\/p>\n<p>On July 29, 2026, the Federal Trade Commission (\u201cFTC\u201d), the People of the State of California through Los Angeles County Counsel, and the Utah Division of Consumer Protection sued Hims &amp; Hers in the Northern District of California.<\/p>\n<p>According to the FTC, the action alleges that Hims &amp; Hers failed to clearly disclose that it charged consumers for prescriptions almost immediately after submission of an intake form, despite representing that consumers would be able to consult with a medical provider to find treatment that was \u201cright for them.\u201d<\/p>\n<p>The FTC also alleges that the Company created obstacles for consumers attempting to cancel subscriptions and misrepresented how their health information would remain private. According to the FTC, Hims &amp; Hers shared consumers\u2019 health information with Meta, Snap, and other third parties.<\/p>\n<p>Following this news, the price of Hims &amp; Hers stock fell <strong>$4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026<\/strong>.<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k39IJQ0n8iQR5MCtfldFr1xN7X9uJj2SB-zRmmVHKde_nJ8BwQTLIUvrqr9ZZRQd0ERorlj66-rTw9P4jEnLq0Qrqvmqt1HRK3Mwu_3Pf31w0lVkBU68bUeyCkLN5NxYofd_2qLExmVuAl9DzzWWqA==\" rel=\"nofollow\" target=\"_blank\">WHY WOLF HALDENSTEIN?<\/a>\n      <\/p>\n<p>This illustrious <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8avRiyEdy6TG349EFmMAsTVXBL4s_1JWWzuIlGkn5Y8bO5x2oJ1RBI54ZbJFjlFh_NS660-k4nsaZX2ZTYnkMc0aObRlXfZDDIPwD5mS0D8NvEpMc8ujzrOatE1tsqm4\" rel=\"nofollow\" target=\"_blank\">firm,<\/a> founded in 1888, remains steadfast in its pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7bFpxMpXjtoSczX_zEurlfD4h6AIDBamaBAxf5GfuOJ--lkjIUJiAwdDAoXkyA6lcsvL_agWsc0V3kOAs8_R4GbP7w7cW4aFCx0M0wCTNXdh_kK02noCA8D0nolDttHA\" rel=\"nofollow\" target=\"_blank\">law firm<\/a> brings more than 125 years of legal expertise in securities litigation and maintains a proven record of protecting investors\u2019 rights.<\/p>\n<p>We encourage all investors who have been affected or who have information that will assist in our investigation to contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oQwpog0aZA1w0n25Lj1q45ZVrvl4TPsciCXktTSbG2bKGayEecCfyb_TNstHuTgVf1e9-IOSvLubRS76WFhqCr5QVZOAxSctPP6In0yzmTEBGBSvY639YnVcqou0xLzBjjRJmvOJnn5GEi2tOWiF9ZWnkhsLHYPfyZTJ-stIT8Y=\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP.<\/a><\/p>\n<p>\n        <strong>There is no cost or obligation to speak with an attorney.<\/strong>\n      <\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<ul>\n<li>\n          <strong>Phone:<\/strong> (800) 575-0735 or (212) 545-4774<\/li>\n<li>\n          <strong>Email:<\/strong> classmember@whafh.com<\/li>\n<li>\n          <strong>Contact Person:<\/strong><br \/>\n          <a href=\"mailto:gstone@whafh.com\" rel=\"nofollow\" target=\"_blank\">Gregory Stone, Director of Case and Financial Analysis<\/a><br \/>\n          \n        <\/li>\n<\/ul>\n<p>\n        <strong>Firm Website:<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oQwpog0aZA1w0n25Lj1q45ZVrvl4TPsciCXktTSbG2bKGayEecCfyb_TNstHuTgVr0UxqnYOpBlarJbEsFHyak8QRYh1WI62rul0aLrpoN3dIQcfUznOOa3u56vquPmlek5rt_6XvmG8GnMJwRdfj13zz5bs4T13ZbFeheJz9Xc=\" rel=\"nofollow\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a>\n      <\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjQyZTYwYTUtZmJiOC00OTZkLWFhYjctOTE1NzkxYzI1N2JmLTEwMjkyNDItMjAyNi0wOS0zMC1lbg==\/tiny\/Wolf-Haldenstein-Adler-Freeman.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Lead Plaintiff Deadline November 2, 2026 NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP (\u201cWolf Haldenstein\u201d), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims &amp; Hers Health, Inc. (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims &amp; Hers securities between August 4, 2025,and July 29, 2026 (the &#8220;Class Period&#8221;). Investors who purchased Hims &amp; Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026. PLEASE CLICK HERE TO SUBMIT CONTACT AND TRADE INFORMATION Allegations The complaint alleges &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1007133","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Lead Plaintiff Deadline November 2, 2026 NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP (\u201cWolf Haldenstein\u201d), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims &amp; Hers Health, Inc. (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims &amp; Hers securities between August 4, 2025,and July 29, 2026 (the &#8220;Class Period&#8221;). Investors who purchased Hims &amp; Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026. PLEASE CLICK HERE TO SUBMIT CONTACT AND TRADE INFORMATION Allegations The complaint alleges &hellip; Continue reading &quot;Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-30T13:29:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately\",\"datePublished\":\"2026-09-30T13:29:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/\"},\"wordCount\":526,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/\",\"name\":\"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=\",\"datePublished\":\"2026-09-30T13:29:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/","og_locale":"en_US","og_type":"article","og_title":"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately - Market Newsdesk","og_description":"Lead Plaintiff Deadline November 2, 2026 NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP (\u201cWolf Haldenstein\u201d), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims &amp; Hers Health, Inc. (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims &amp; Hers securities between August 4, 2025,and July 29, 2026 (the &#8220;Class Period&#8221;). Investors who purchased Hims &amp; Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026. PLEASE CLICK HERE TO SUBMIT CONTACT AND TRADE INFORMATION Allegations The complaint alleges &hellip; Continue reading \"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-30T13:29:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately","datePublished":"2026-09-30T13:29:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/"},"wordCount":526,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/","name":"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=","datePublished":"2026-09-30T13:29:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgzNjMxMiM3ODcwMjgxIzIwMTc2NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-lost-money-in-shares-of-acquired-hims-hers-health-inc-nyse-hims-should-contact-wolf-haldenstein-immediately-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholders who lost money in shares of acquired Hims &amp; Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1007133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1007133"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1007133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1007133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1007133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1007133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}